Join BJS Academy
BJS Academy>Randomized clinical ...>Covered versus bare ...
Normal View Dyslexic View

Covered versus bare-metal stenting of the mesenteric arteries in patients with chronic mesenteric ischaemia (CoBaGI): a multicentre, patient-blinded and investigator-blinded, randomised controlled trial.

16 August 2024
Randomized clinical trials Vascular
Terlouw LG, van Dijk LJD, van Noord D, Bakker OJ, Bijdevaate DC, Erler NS et al, on behalf of the Dutch Mesenteric Ischemia Study Group.

Lancet Gastrohepatol 2024; 9: 299-309.

Ninety-four patients with chronic mesenteric ischaemia were included. Only one patient died. After 24 months, the patency of covered stents was better than bare metal stents: 81 versus 49 per cent, P<0.0001. Access site adverse events were more common in covered stent procedures.

Comment: This study does not address whether symptoms were improved alongside patency.

BJS Foundation Limited
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
rct274
Randomized clinical trials
Randomized clinical trials
Vascular
Covered versus bare-metal stenting of the mesenteric arteries in patients with chronic mesenteric ischaemia (CoBaGI): a multicentre, patient-blinded and investigator-blinded, randomised controlled trial.
Terlouw LG, van Dijk LJD, van Noord D, Bakker OJ, Bijdevaate DC, Erler NS et al, on behalf of the Dutch Mesenteric Ischemia Study Group.
16082024
Lancet Gastrohepatol 2024; 9: 299-309.
Ninety-four patients with chronic mesenteric ischaemia were included. Only one patient died. After 24 months, the patency of covered stents was better than bare metal stents: 81 versus 49 per cent, P<0.0001. Access site adverse events were more common in covered stent procedures.
Comment: This study does not address whether symptoms were improved alongside patency.
Published on: 16 August 2024
Article ID: rct274

Related articles

Ten-year outcomes of a randomized clinical trial of endothermal ablation versus conventional surgery for great saphenous varicose veins

Mohamed AH, Howitt A, Rae S, Cai PL, Hitchman L, Wallace T et al.

18 September 2024

Effect of anticoagulant therapy for 6 weeks vs 3 months on recurrence and bleeding events in patients younger than 21 years of age with provoked venous thromboembolism. The Kids-DOTT randomized clinical trial.

Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA et al, for the Kids-DOTT Trial investigators and the ATLAS Group.
JAMA 2022; 327: 129-137.

1 February 2022

Extended-course antibiotic prophylaxis in lower limb amputation: randomized clinical trial.

Souroullas P, Barnes R, Carradice D, Smith G, Huang C, Chetter I.

2 May 2022
  • Normal view
  • Dyslexic view
Copied!